{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T04:44:05Z","timestamp":1777869845562,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MST 110-2314-B-002-138-MY3"],"award-info":[{"award-number":["MST 110-2314-B-002-138-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 110-N4983"],"award-info":[{"award-number":["NTUH 110-N4983"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ijrobp.2023.02.014","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T21:02:19Z","timestamp":1676322139000},"page":"1135-1149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cisplatin and Albumin-Based Gold\u2013Cisplatin Nanoparticles Enhance Ablative Radiation Therapy\u2013Induced Antitumor Immunity in Local and Distant Tumor Microenvironment"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8553-8069","authenticated-orcid":false,"given":"Jenny Ling-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Jyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Kai","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Cheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Yi","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Sen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Hsin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Jium","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.02.014_bib0001","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00066-018-1418-8","article-title":"Predicting tumor responses and patient survival in chemoradiotherapy-treated patients with non-small-cell lung cancer using dynamic contrast-enhanced integrated magnetic resonance-positron-emission tomography","volume":"195","author":"Huang","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0002","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1158\/2326-6066.CIR-18-0654","article-title":"Radiotherapy and cisplatin increase immunotherapy efficacy by enabling local and systemic intratumoral T-cell activity","volume":"7","author":"Kroon","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0003","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00262-020-02690-w","article-title":"Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors","volume":"70","author":"Chen","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0004","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0005","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1001\/jamaoncol.2015.2756","article-title":"Role of local radiation therapy in cancer immunotherapy","volume":"1","author":"Demaria","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0006","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/onc.2016.104","article-title":"Damage-associated molecular patterns in cancer: A double-edged sword","volume":"35","author":"Hernandez","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0007","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jnci\/djs629","article-title":"Combining radiotherapy and cancer immunotherapy: A paradigm shift","volume":"105","author":"Formenti","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0008","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.6543","article-title":"Phase I dose escalation of stereotactic body radiation therapy and concurrent cisplatin for re-irradiation of unresectable, recurrent head and neck squamous cell carcinoma","volume":"38","author":"Echevarria","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0009","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Enhancing cancer immunotherapy with nanomedicine","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2013.02.009","article-title":"Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer","volume":"86","author":"Werner","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0011","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/nano6060116","article-title":"Human serum albumin nanoparticles for use in cancer drug delivery: Process optimization and in vitro characterization","volume":"6","author":"Lomis","year":"2016","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0012","doi-asserted-by":"crossref","first-page":"7932","DOI":"10.3390\/ijms21217932","article-title":"Efficacy and safety of human serum albumin\u2013cisplatin complex in U87MG xenograft mouse models","volume":"21","author":"Park","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0013","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.7150\/thno.22172","article-title":"Metal-based nanoenhancers for future radiotherapy: Radiosensitizing and synergistic effects on tumor cells","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0014","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2011.08.026","article-title":"Nanodosimetric effects of gold nanoparticles in megavoltage radiation therapy","volume":"100","author":"McMahon","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12645-016-0021-x","article-title":"Gold nanoparticles for cancer radiotherapy: A review","volume":"7","author":"Haume","year":"2016","journal-title":"Cancer Nanotechnol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0016","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.radonc.2013.12.013","article-title":"Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions","volume":"110","author":"Jain","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0017","article-title":"Harnessing the immunogenic potential of gold nanoparticle-based platforms as a therapeutic strategy in breast cancer immunotherapy: A mini review","volume":"13","author":"Chen","year":"2022","journal-title":"Frontiers Immunol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0018","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/15384047.2020.1861923","article-title":"Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer","volume":"22","author":"Janic","year":"2021","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0019","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-19-1344","article-title":"Cisplatin facilitates radiation-induced abscopal effects in conjunction with PD-1 checkpoint blockade through CXCR3\/CXCL10-mediated T-cell recruitment","volume":"25","author":"Luo","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0020","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1039\/D1BM00112D","article-title":"Cisplatin nanoparticles boost abscopal effect of radiation plus anti-PD1 therapy","volume":"9","author":"Wang","year":"2021","journal-title":"Biomater Sci"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0021","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00066-021-01835-9","article-title":"Preclinical evaluation of pegylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer","volume":"197","author":"Chen","year":"2021","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0022","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/HP.0000000000000462","article-title":"Dosimetry formalism and implementation of a homogenous irradiation protocol to improve the accuracy of small animal whole-body irradiation using a 137Cs irradiator","volume":"110","author":"Brodin","year":"2016","journal-title":"Health Phys"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0023","first-page":"1667","article-title":"Radiosensitization by irinotecan is attributed to G2\/M phase arrest, followed by enhanced apoptosis, probably through the ATM\/Chk\/CDC25C\/CDC2 pathway in p53-mutant colorectal cancer cells","volume":"53","author":"Wang","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/CAD.0000000000000157","article-title":"Bi 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments","volume":"26","author":"Bogado","year":"2015","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0025","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0026","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-4598-12-94","article-title":"Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes","volume":"12","author":"Gomez-Casal","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0027","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0028","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"Synergyfinder 2.0: Visual analytics of multi-drug combination synergies","volume":"48","author":"Lanevski","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0029","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1186\/s12885-017-3924-y","article-title":"Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells","volume":"17","author":"Chang","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0030","first-page":"2190","article-title":"Synergy between angiostatin and endostatin: Inhibition of ovarian cancer growth","volume":"60","author":"Yokoyama","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0031","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/1541-7786.MCR-04-0032","article-title":"Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining","volume":"3","author":"Boeckman","year":"2005","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0032","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3892\/ol.2014.2049","article-title":"Synergistic killing of lung cancer cells by cisplatin and radiation via autophagy and apoptosis","volume":"7","author":"Liu","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0033","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI67313","article-title":"Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice","volume":"124","author":"Deng","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0034","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijrobp.2020.04.013","article-title":"Targeting mertk enhances adaptive immune responses after radiation therapy","volume":"108","author":"Tormoen","year":"2020","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0035","first-page":"159","article-title":"Radiation modulates tumor antigen presentation by dendritic cells","volume":"64","author":"Liao","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0036","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nnano.2017.113","article-title":"Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy","volume":"12","author":"Min","year":"2017","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0037","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/2326-6066.CIR-14-0196","article-title":"Stereotactic radiation therapy augments antigen-specific PD-1-mediated antitumor immune responses via cross-presentation of tumor antigen","volume":"3","author":"Sharabi","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0038","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2217\/nnm.13.191","article-title":"Shaping cancer nanomedicine: The effect of particle shape on the in vivo journey of nanoparticles","volume":"9","author":"Toy","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0039","doi-asserted-by":"crossref","first-page":"26841","DOI":"10.1021\/acsami.8b01546","article-title":"Interaction of positively charged gold nanoparticles with cancer cells monitored by an in situ label-free optical biosensor and transmission electron microscopy","volume":"10","author":"Peter","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijrobp.2022.07.034","article-title":"Xenon-enhanced ventilation ct for functional lung avoidance radiotherapy in patients with lung cancer","volume":"115","author":"Huang","year":"2023","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0041","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/1078-0432.CCR-14-2824","article-title":"Ablative tumor radiation can change the tumor immune cell microenvironment to induce durable complete remissions","volume":"21","author":"Filatenkov","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004306","article-title":"Harnessing radiotherapy-induced nNK-cell activity by combining DNA damage\u2013response inhibition and immune checkpoint blockade","volume":"10","author":"Patin","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ijrobp.2023.02.014_bib0043","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001845","article-title":"Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent\/metastatic cancer to immune checkpoint inhibitors","volume":"9","author":"Zhou","year":"2021","journal-title":"J Immunother Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162300158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030162300158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:49:21Z","timestamp":1777560561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030162300158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S036030162300158X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.02.014","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cisplatin and Albumin-Based Gold\u2013Cisplatin Nanoparticles Enhance Ablative Radiation Therapy\u2013Induced Antitumor Immunity in Local and Distant Tumor Microenvironment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}